Cargando…

ONEST (Observers Needed to Evaluate Subjective Tests) Analysis of Stromal Tumour-Infiltrating Lymphocytes (sTILs) in Breast Cancer and Its Limitations

SIMPLE SUMMARY: Tumour-infiltrating lymphocytes (TILs) reflect the host’s response against tumours. TILs have a strong prognostic effect in the so-called triple-negative (oestrogen receptor, progesterone receptor, and human epidermal growth factor receptor-2 negative) subset of breast cancers and pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Cserni, Bálint, Kilmartin, Darren, O’Loughlin, Mark, Andreu, Xavier, Bagó-Horváth, Zsuzsanna, Bianchi, Simonetta, Chmielik, Ewa, Figueiredo, Paulo, Floris, Giuseppe, Foschini, Maria Pia, Kovács, Anikó, Heikkilä, Päivi, Kulka, Janina, Laenkholm, Anne-Vibeke, Liepniece-Karele, Inta, Marchiò, Caterina, Provenzano, Elena, Regitnig, Peter, Reiner, Angelika, Ryška, Aleš, Sapino, Anna, Stovgaard, Elisabeth Specht, Quinn, Cecily, Zolota, Vasiliki, Webber, Mark, Glynn, Sharon A., Bori, Rita, Csörgő, Erika, Oláh-Németh, Orsolya, Pancsa, Tamás, Sejben, Anita, Sejben, István, Vörös, András, Zombori, Tamás, Nyári, Tibor, Callagy, Grace, Cserni, Gábor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954449/
https://www.ncbi.nlm.nih.gov/pubmed/36831541
http://dx.doi.org/10.3390/cancers15041199
_version_ 1784894120190279680
author Cserni, Bálint
Kilmartin, Darren
O’Loughlin, Mark
Andreu, Xavier
Bagó-Horváth, Zsuzsanna
Bianchi, Simonetta
Chmielik, Ewa
Figueiredo, Paulo
Floris, Giuseppe
Foschini, Maria Pia
Kovács, Anikó
Heikkilä, Päivi
Kulka, Janina
Laenkholm, Anne-Vibeke
Liepniece-Karele, Inta
Marchiò, Caterina
Provenzano, Elena
Regitnig, Peter
Reiner, Angelika
Ryška, Aleš
Sapino, Anna
Stovgaard, Elisabeth Specht
Quinn, Cecily
Zolota, Vasiliki
Webber, Mark
Glynn, Sharon A.
Bori, Rita
Csörgő, Erika
Oláh-Németh, Orsolya
Pancsa, Tamás
Sejben, Anita
Sejben, István
Vörös, András
Zombori, Tamás
Nyári, Tibor
Callagy, Grace
Cserni, Gábor
author_facet Cserni, Bálint
Kilmartin, Darren
O’Loughlin, Mark
Andreu, Xavier
Bagó-Horváth, Zsuzsanna
Bianchi, Simonetta
Chmielik, Ewa
Figueiredo, Paulo
Floris, Giuseppe
Foschini, Maria Pia
Kovács, Anikó
Heikkilä, Päivi
Kulka, Janina
Laenkholm, Anne-Vibeke
Liepniece-Karele, Inta
Marchiò, Caterina
Provenzano, Elena
Regitnig, Peter
Reiner, Angelika
Ryška, Aleš
Sapino, Anna
Stovgaard, Elisabeth Specht
Quinn, Cecily
Zolota, Vasiliki
Webber, Mark
Glynn, Sharon A.
Bori, Rita
Csörgő, Erika
Oláh-Németh, Orsolya
Pancsa, Tamás
Sejben, Anita
Sejben, István
Vörös, András
Zombori, Tamás
Nyári, Tibor
Callagy, Grace
Cserni, Gábor
author_sort Cserni, Bálint
collection PubMed
description SIMPLE SUMMARY: Tumour-infiltrating lymphocytes (TILs) reflect the host’s response against tumours. TILs have a strong prognostic effect in the so-called triple-negative (oestrogen receptor, progesterone receptor, and human epidermal growth factor receptor-2 negative) subset of breast cancers and predict a better response when primary systemic (neoadjuvant) treatment is administered. Although they are easy to assess, their quantitative assessment is subject to some inter-observer variation. ONEST (Observers Needed to Evaluate Subjective Tests) is a new way of analysing inter-observer variability and helps in estimating the number of observers required for a more reliable estimation of this phenomenon. This aspect of reproducibility for TILs has not been explored previously. Our analysis suggests that between six and nine pathologists can give a good approximation of inter-observer agreement in TIL assessments. ABSTRACT: Tumour-infiltrating lymphocytes (TILs) reflect antitumour immunity. Their evaluation of histopathology specimens is influenced by several factors and is subject to issues of reproducibility. ONEST (Observers Needed to Evaluate Subjective Tests) helps in determining the number of observers that would be sufficient for the reliable estimation of inter-observer agreement of TIL categorisation. This has not been explored previously in relation to TILs. ONEST analyses, using an open-source software developed by the first author, were performed on TIL quantification in breast cancers taken from two previous studies. These were one reproducibility study involving 49 breast cancers, 23 in the first circulation and 14 pathologists in the second circulation, and one study involving 100 cases and 9 pathologists. In addition to the estimates of the number of observers required, other factors influencing the results of ONEST were examined. The analyses reveal that between six and nine observers (range 2–11) are most commonly needed to give a robust estimate of reproducibility. In addition, the number and experience of observers, the distribution of values around or away from the extremes, and outliers in the classification also influence the results. Due to the simplicity and the potentially relevant information it may give, we propose ONEST to be a part of new reproducibility analyses.
format Online
Article
Text
id pubmed-9954449
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-99544492023-02-25 ONEST (Observers Needed to Evaluate Subjective Tests) Analysis of Stromal Tumour-Infiltrating Lymphocytes (sTILs) in Breast Cancer and Its Limitations Cserni, Bálint Kilmartin, Darren O’Loughlin, Mark Andreu, Xavier Bagó-Horváth, Zsuzsanna Bianchi, Simonetta Chmielik, Ewa Figueiredo, Paulo Floris, Giuseppe Foschini, Maria Pia Kovács, Anikó Heikkilä, Päivi Kulka, Janina Laenkholm, Anne-Vibeke Liepniece-Karele, Inta Marchiò, Caterina Provenzano, Elena Regitnig, Peter Reiner, Angelika Ryška, Aleš Sapino, Anna Stovgaard, Elisabeth Specht Quinn, Cecily Zolota, Vasiliki Webber, Mark Glynn, Sharon A. Bori, Rita Csörgő, Erika Oláh-Németh, Orsolya Pancsa, Tamás Sejben, Anita Sejben, István Vörös, András Zombori, Tamás Nyári, Tibor Callagy, Grace Cserni, Gábor Cancers (Basel) Article SIMPLE SUMMARY: Tumour-infiltrating lymphocytes (TILs) reflect the host’s response against tumours. TILs have a strong prognostic effect in the so-called triple-negative (oestrogen receptor, progesterone receptor, and human epidermal growth factor receptor-2 negative) subset of breast cancers and predict a better response when primary systemic (neoadjuvant) treatment is administered. Although they are easy to assess, their quantitative assessment is subject to some inter-observer variation. ONEST (Observers Needed to Evaluate Subjective Tests) is a new way of analysing inter-observer variability and helps in estimating the number of observers required for a more reliable estimation of this phenomenon. This aspect of reproducibility for TILs has not been explored previously. Our analysis suggests that between six and nine pathologists can give a good approximation of inter-observer agreement in TIL assessments. ABSTRACT: Tumour-infiltrating lymphocytes (TILs) reflect antitumour immunity. Their evaluation of histopathology specimens is influenced by several factors and is subject to issues of reproducibility. ONEST (Observers Needed to Evaluate Subjective Tests) helps in determining the number of observers that would be sufficient for the reliable estimation of inter-observer agreement of TIL categorisation. This has not been explored previously in relation to TILs. ONEST analyses, using an open-source software developed by the first author, were performed on TIL quantification in breast cancers taken from two previous studies. These were one reproducibility study involving 49 breast cancers, 23 in the first circulation and 14 pathologists in the second circulation, and one study involving 100 cases and 9 pathologists. In addition to the estimates of the number of observers required, other factors influencing the results of ONEST were examined. The analyses reveal that between six and nine observers (range 2–11) are most commonly needed to give a robust estimate of reproducibility. In addition, the number and experience of observers, the distribution of values around or away from the extremes, and outliers in the classification also influence the results. Due to the simplicity and the potentially relevant information it may give, we propose ONEST to be a part of new reproducibility analyses. MDPI 2023-02-14 /pmc/articles/PMC9954449/ /pubmed/36831541 http://dx.doi.org/10.3390/cancers15041199 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Cserni, Bálint
Kilmartin, Darren
O’Loughlin, Mark
Andreu, Xavier
Bagó-Horváth, Zsuzsanna
Bianchi, Simonetta
Chmielik, Ewa
Figueiredo, Paulo
Floris, Giuseppe
Foschini, Maria Pia
Kovács, Anikó
Heikkilä, Päivi
Kulka, Janina
Laenkholm, Anne-Vibeke
Liepniece-Karele, Inta
Marchiò, Caterina
Provenzano, Elena
Regitnig, Peter
Reiner, Angelika
Ryška, Aleš
Sapino, Anna
Stovgaard, Elisabeth Specht
Quinn, Cecily
Zolota, Vasiliki
Webber, Mark
Glynn, Sharon A.
Bori, Rita
Csörgő, Erika
Oláh-Németh, Orsolya
Pancsa, Tamás
Sejben, Anita
Sejben, István
Vörös, András
Zombori, Tamás
Nyári, Tibor
Callagy, Grace
Cserni, Gábor
ONEST (Observers Needed to Evaluate Subjective Tests) Analysis of Stromal Tumour-Infiltrating Lymphocytes (sTILs) in Breast Cancer and Its Limitations
title ONEST (Observers Needed to Evaluate Subjective Tests) Analysis of Stromal Tumour-Infiltrating Lymphocytes (sTILs) in Breast Cancer and Its Limitations
title_full ONEST (Observers Needed to Evaluate Subjective Tests) Analysis of Stromal Tumour-Infiltrating Lymphocytes (sTILs) in Breast Cancer and Its Limitations
title_fullStr ONEST (Observers Needed to Evaluate Subjective Tests) Analysis of Stromal Tumour-Infiltrating Lymphocytes (sTILs) in Breast Cancer and Its Limitations
title_full_unstemmed ONEST (Observers Needed to Evaluate Subjective Tests) Analysis of Stromal Tumour-Infiltrating Lymphocytes (sTILs) in Breast Cancer and Its Limitations
title_short ONEST (Observers Needed to Evaluate Subjective Tests) Analysis of Stromal Tumour-Infiltrating Lymphocytes (sTILs) in Breast Cancer and Its Limitations
title_sort onest (observers needed to evaluate subjective tests) analysis of stromal tumour-infiltrating lymphocytes (stils) in breast cancer and its limitations
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954449/
https://www.ncbi.nlm.nih.gov/pubmed/36831541
http://dx.doi.org/10.3390/cancers15041199
work_keys_str_mv AT csernibalint onestobserversneededtoevaluatesubjectivetestsanalysisofstromaltumourinfiltratinglymphocytesstilsinbreastcanceranditslimitations
AT kilmartindarren onestobserversneededtoevaluatesubjectivetestsanalysisofstromaltumourinfiltratinglymphocytesstilsinbreastcanceranditslimitations
AT oloughlinmark onestobserversneededtoevaluatesubjectivetestsanalysisofstromaltumourinfiltratinglymphocytesstilsinbreastcanceranditslimitations
AT andreuxavier onestobserversneededtoevaluatesubjectivetestsanalysisofstromaltumourinfiltratinglymphocytesstilsinbreastcanceranditslimitations
AT bagohorvathzsuzsanna onestobserversneededtoevaluatesubjectivetestsanalysisofstromaltumourinfiltratinglymphocytesstilsinbreastcanceranditslimitations
AT bianchisimonetta onestobserversneededtoevaluatesubjectivetestsanalysisofstromaltumourinfiltratinglymphocytesstilsinbreastcanceranditslimitations
AT chmielikewa onestobserversneededtoevaluatesubjectivetestsanalysisofstromaltumourinfiltratinglymphocytesstilsinbreastcanceranditslimitations
AT figueiredopaulo onestobserversneededtoevaluatesubjectivetestsanalysisofstromaltumourinfiltratinglymphocytesstilsinbreastcanceranditslimitations
AT florisgiuseppe onestobserversneededtoevaluatesubjectivetestsanalysisofstromaltumourinfiltratinglymphocytesstilsinbreastcanceranditslimitations
AT foschinimariapia onestobserversneededtoevaluatesubjectivetestsanalysisofstromaltumourinfiltratinglymphocytesstilsinbreastcanceranditslimitations
AT kovacsaniko onestobserversneededtoevaluatesubjectivetestsanalysisofstromaltumourinfiltratinglymphocytesstilsinbreastcanceranditslimitations
AT heikkilapaivi onestobserversneededtoevaluatesubjectivetestsanalysisofstromaltumourinfiltratinglymphocytesstilsinbreastcanceranditslimitations
AT kulkajanina onestobserversneededtoevaluatesubjectivetestsanalysisofstromaltumourinfiltratinglymphocytesstilsinbreastcanceranditslimitations
AT laenkholmannevibeke onestobserversneededtoevaluatesubjectivetestsanalysisofstromaltumourinfiltratinglymphocytesstilsinbreastcanceranditslimitations
AT liepniecekareleinta onestobserversneededtoevaluatesubjectivetestsanalysisofstromaltumourinfiltratinglymphocytesstilsinbreastcanceranditslimitations
AT marchiocaterina onestobserversneededtoevaluatesubjectivetestsanalysisofstromaltumourinfiltratinglymphocytesstilsinbreastcanceranditslimitations
AT provenzanoelena onestobserversneededtoevaluatesubjectivetestsanalysisofstromaltumourinfiltratinglymphocytesstilsinbreastcanceranditslimitations
AT regitnigpeter onestobserversneededtoevaluatesubjectivetestsanalysisofstromaltumourinfiltratinglymphocytesstilsinbreastcanceranditslimitations
AT reinerangelika onestobserversneededtoevaluatesubjectivetestsanalysisofstromaltumourinfiltratinglymphocytesstilsinbreastcanceranditslimitations
AT ryskaales onestobserversneededtoevaluatesubjectivetestsanalysisofstromaltumourinfiltratinglymphocytesstilsinbreastcanceranditslimitations
AT sapinoanna onestobserversneededtoevaluatesubjectivetestsanalysisofstromaltumourinfiltratinglymphocytesstilsinbreastcanceranditslimitations
AT stovgaardelisabethspecht onestobserversneededtoevaluatesubjectivetestsanalysisofstromaltumourinfiltratinglymphocytesstilsinbreastcanceranditslimitations
AT quinncecily onestobserversneededtoevaluatesubjectivetestsanalysisofstromaltumourinfiltratinglymphocytesstilsinbreastcanceranditslimitations
AT zolotavasiliki onestobserversneededtoevaluatesubjectivetestsanalysisofstromaltumourinfiltratinglymphocytesstilsinbreastcanceranditslimitations
AT webbermark onestobserversneededtoevaluatesubjectivetestsanalysisofstromaltumourinfiltratinglymphocytesstilsinbreastcanceranditslimitations
AT glynnsharona onestobserversneededtoevaluatesubjectivetestsanalysisofstromaltumourinfiltratinglymphocytesstilsinbreastcanceranditslimitations
AT boririta onestobserversneededtoevaluatesubjectivetestsanalysisofstromaltumourinfiltratinglymphocytesstilsinbreastcanceranditslimitations
AT csorgoerika onestobserversneededtoevaluatesubjectivetestsanalysisofstromaltumourinfiltratinglymphocytesstilsinbreastcanceranditslimitations
AT olahnemethorsolya onestobserversneededtoevaluatesubjectivetestsanalysisofstromaltumourinfiltratinglymphocytesstilsinbreastcanceranditslimitations
AT pancsatamas onestobserversneededtoevaluatesubjectivetestsanalysisofstromaltumourinfiltratinglymphocytesstilsinbreastcanceranditslimitations
AT sejbenanita onestobserversneededtoevaluatesubjectivetestsanalysisofstromaltumourinfiltratinglymphocytesstilsinbreastcanceranditslimitations
AT sejbenistvan onestobserversneededtoevaluatesubjectivetestsanalysisofstromaltumourinfiltratinglymphocytesstilsinbreastcanceranditslimitations
AT vorosandras onestobserversneededtoevaluatesubjectivetestsanalysisofstromaltumourinfiltratinglymphocytesstilsinbreastcanceranditslimitations
AT zomboritamas onestobserversneededtoevaluatesubjectivetestsanalysisofstromaltumourinfiltratinglymphocytesstilsinbreastcanceranditslimitations
AT nyaritibor onestobserversneededtoevaluatesubjectivetestsanalysisofstromaltumourinfiltratinglymphocytesstilsinbreastcanceranditslimitations
AT callagygrace onestobserversneededtoevaluatesubjectivetestsanalysisofstromaltumourinfiltratinglymphocytesstilsinbreastcanceranditslimitations
AT csernigabor onestobserversneededtoevaluatesubjectivetestsanalysisofstromaltumourinfiltratinglymphocytesstilsinbreastcanceranditslimitations